February 2017
VIIAD
Petsky Prunier advises Healthcare Technology Company VIIAD on its growth Investment
February 27, 2017 (New York, NY) – Petsky Prunier is pleased to announce it has advised VIIAD Systems, LLC, a leading healthcare technology company, on its growth investment from an undisclosed group of investors.
Petsky Prunier, with a team led by managing director Christopher French, served as exclusive financial advisor to VIIAD.
More Like This
-
C$3.3bPending Completion
dentalcorp
Financial Advisor to dentalcorp Holdings on its Sale to GTCR
-
Kent-Athlone Pharma Group
Exclusive Financial Advisor to Kent-Athlone Pharma Group on the Sale of Athlone Laboratories to Gaelic Laboratories
-
US$140m
Trulieve Cannabis
Sole Agent and Sole Bookrunner (Senior Secured Notes Offering)